-
1
-
-
33748544772
-
-
The European Group on Ethics in Science and New Technologies to the European Commission. Luxembourg: Office for Official Publications of the European Communities.
-
The European Group on Ethics in Science and New Technologies to the European Commission. 2003. Opinion on the ethical aspects of research in developing countries. Luxembourg: Office for Official Publications of the European Communities.
-
(2003)
Opinion on the Ethical Aspects of Research in Developing Countries
-
-
-
4
-
-
37249036724
-
-
See Section 5. The availability of proven treatment as a condition for the use of placebo.
-
See Section 5. The availability of proven treatment as a condition for the use of placebo.
-
-
-
-
5
-
-
37249084215
-
-
World Medical Association. 2002. Declaration of Helsinki.
-
World Medical Association. 2002. Declaration of Helsinki.
-
-
-
-
6
-
-
0003433351
-
-
Council for International Organizations of Medical Sciences CIOMS in collaboration with the World Health Organization. Geneva.
-
Council for International Organizations of Medical Sciences CIOMS in collaboration with the World Health Organization. 2002. International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva.
-
(2002)
International Ethical Guidelines for Biomedical Research Involving Human Subjects
-
-
-
7
-
-
37249009339
-
-
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Choice of Control Group and Related Issues in Clinical Trials. E 10.
-
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2000. ICH Harmonised Tripartite Guideline. Choice of Control Group and Related Issues in Clinical Trials. E 10.
-
(2000)
ICH Harmonised Tripartite Guideline
-
-
-
10
-
-
0030775618
-
The Ethics of Clinical Research in the Third World
-
M. Angell. The Ethics of Clinical Research in the Third World. NEJM 1997; 337: 847-849.
-
(1997)
NEJM
, vol.337
, pp. 847-849
-
-
Angell, M.1
-
11
-
-
0030228704
-
Placebo Orthodoxy in Clinical Research I: Empirical and Methodological Myths
-
B. Freedman et al. Placebo Orthodoxy in Clinical Research I: Empirical and Methodological Myths. JLME 1996; 24: 243-251.
-
(1996)
JLME
, vol.24
, pp. 243-251
-
-
Freedman, B.1
-
12
-
-
0034641552
-
For and against
-
K.J. Rothmann et al. For and against. BMJ 2000; 321: 442-445.
-
(2000)
BMJ
, vol.321
, pp. 442-445
-
-
Rothmann, K.J.1
-
13
-
-
37249083668
-
-
We are only using simplified formulations of each criterion to illustrate each principle with an example. These formulations are neither exactly corresponding to one of the guidelines nor to our preferences for detailed, elaborated ethical principles.
-
We are only using simplified formulations of each criterion to illustrate each principle with an example. These formulations are neither exactly corresponding to one of the guidelines nor to our preferences for detailed, elaborated ethical principles.
-
-
-
-
14
-
-
0028070548
-
The Continuing Unethical Use of Placebo Controls
-
K.B. Michels et al. The Continuing Unethical Use of Placebo Controls. NEJM 1994; 331: 394-398.
-
(1994)
NEJM
, vol.331
, pp. 394-398
-
-
Michels, K.B.1
-
15
-
-
2942512903
-
The revision of the Declaration of Helsinki: Past, present and future
-
Cf. e.g.
-
Cf. e.g. R.V. Carlson et al. The revision of the Declaration of Helsinki: past, present and future. BrJClinPharmacol 2004; 57: 700.
-
(2004)
BrJClinPharmacol
, vol.57
, pp. 700
-
-
Carlson, R.V.1
-
16
-
-
0037389433
-
Update on unethical use of placebos in randomised trials
-
E.g.
-
E.g. K. Michels et al. Update on unethical use of placebos in randomised trials. Bioethics 2003; 17: 188-204.
-
(2003)
Bioethics
, vol.17
, pp. 188-204
-
-
Michels, K.1
-
17
-
-
2342428820
-
The standard of care debate: The Declaration of Helsinki versus the international consensus opinion
-
This is the opinion of
-
This is the opinion of R.K. Lie et al. The standard of care debate: the Declaration of Helsinki versus the international consensus opinion. J Med Ethics 2004; 30: 190.
-
(2004)
J Med Ethics
, vol.30
, pp. 190
-
-
Lie, R.K.1
-
18
-
-
0037312999
-
The Declaration of Helsinki and Clinical Trials: A Focus on Placebo-Controlled Trials in Schizophrenia
-
E.g.
-
E.g. W.T. Carpenter et al. The Declaration of Helsinki and Clinical Trials: A Focus on Placebo-Controlled Trials in Schizophrenia. AmJPsych 2003; 160: 356-362.
-
(2003)
AmJPsych
, vol.160
, pp. 356-362
-
-
Carpenter, W.T.1
-
20
-
-
0033558325
-
Placebo-controlled trials in shizophrenia: Are they ethical? Are they necessary
-
Michels, op. cit. note 13.
-
C. Weijer. Placebo-controlled trials in shizophrenia: Are they ethical? Are they necessary. Schizophrenia Research 1999; 35: 211-218. Michels, op. cit. note 13.
-
(1999)
Schizophrenia Research
, vol.35
, pp. 211-218
-
-
Weijer, C.1
-
21
-
-
37249059070
-
-
Freedman, op. cit. note 10, p. 24.
-
Freedman, op. cit. note 10, p. 24.
-
-
-
-
22
-
-
37249025873
-
-
Freedman, op. cit. note 10.
-
Freedman, op. cit. note 10.
-
-
-
-
23
-
-
37249086365
-
-
Macklin, op. cit. note 17.
-
Macklin, op. cit. note 17.
-
-
-
-
24
-
-
37249092205
-
-
The European Group on Ethics in Science and New Technologies to the European Commission op. cit. note 1, 2.10 The use of placebo.
-
The European Group on Ethics in Science and New Technologies to the European Commission op. cit. note 1, 2.10 The use of placebo.
-
-
-
-
25
-
-
37249028377
-
-
The European Group on Ethics in Science and New Technologies to the European Commission op. cit. note 1.
-
The European Group on Ethics in Science and New Technologies to the European Commission op. cit. note 1.
-
-
-
-
26
-
-
0342657088
-
Protecting the vulnerable: Testing times for clinical research ethics
-
Macklin op. cit. note 18.
-
U. Schüklenk. Protecting the vulnerable: testing times for clinical research ethics. Social Science and Medicine 2000; 51: 969-977. Macklin op. cit. note 18.
-
(2000)
Social Science and Medicine
, vol.51
, pp. 969-977
-
-
Schüklenk, U.1
|